Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Discover how AI-powered DeepMerkel improves survival predictions for Merkel cell carcinoma, offering personalized treatment insights for better outcomes.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) ...

In what is being called a major leap forward for cancer care, researchers have developed an artificial intelligence (AI) ...

The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...

University of Washington School of Medicine and Fred Hutchinson Cancer Center, both based in Seattle, have launched a new institute dedicated to treating a rare, aggressive form of skin cancer.

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Machine learning tools can improve personalised prognostication of aggressive skin cancers such as Merkel cell carcinoma, a ...

Newcastle University research team develops AI system to personalise treatment outcomes for Merkel cell carcinoma and other aggressive skin cancers ...

An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.